Diaverum expands network with new dialysis clinic in São Paulo
Malmö, Sweden, 19 June 2025 – Diaverum, the Swedish-born global renal care provider, today announced its acquisition of UNTR clinic, located in Santana de Parnaíba in the São Paulo metropolitan region. This marks the company’s second acquisition in São Paulo in less than a year, in addition to the opening of its clinic in Aracaju, Sergipe.
The new clinic currently operates 37 dialysis machines, serving approximately 180 chronic kidney disease (CKD) patients under Brazil’s public healthcare system (Sistema Único de Saúde - SUS). Its core service is haemodialysis, complemented by comprehensive multidisciplinary care through specialist consultations, nutritional support, and social services – an integral part of Diaverum’s holistic, standardised and proprietary Care Delivery Model.
With the infrastructure already in place, the facility is equipped to scale its operations and treat up to 360 patients. The clinic also provides pre-dialysis care, delivered by a multidisciplinary team comprising nephrologists, nutritionists, psychologists, nurses, and social workers. These existing capabilities offer a strong foundation for integration into Diaverum’s global clinical ecosystem, while enabling future enhancements such as expanded digital services and advanced therapies.
With this acquisition, Diaverum Brazil now operates 13 clinics, including a Vascular Access Centre, serving over 4,800 patients with the support of more than 1,400 healthcare professionals. This follows the recent opening of its Aracaju centre –at 2,700 m², one of the country’s largest dialysis centres. Taken together, these developments demonstrate Diaverum’s continued investment in expanding access, capacity, and quality of care for patients living with CKD.
According to the Brazilian Dialysis Survey 2023, as of 1 July 2023, there were an estimated 157,357 patients undergoing dialysis in Brazil. This data underscores the growing demand for dialysis services, particularly in densely populated regions like Greater São Paulo. The establishment of Diaverum’s new clinic directly addresses this rising need by expanding treatment capacity in a rapidly developing area, thereby enhancing access to life-enhancing renal care for patients in the region.
Additionally, the facility opens new opportunities for partnerships with health insurers, reinforcing Diaverum’s commitment to broadening access to high-quality renal treatments for patients of all profiles.
Rafael Romanini, Diaverum’s CEO, commented: “Since 2017, Diaverum has ambitiously expanded its footprint in Brazil, focusing on regions with growing populations and unmet medical needs. We are committed to enhancing the lives of people with chronic kidney disease, by offering world-class care, supported by our digital infrastructure and innovative solutions.
The integration of the UNTR clinic is not only a strategic milestone, but a reflection of our purpose: to make high-quality care accessible to more patients, where and when they need it most”.
Luciano Bonaldo, Country Manager for Diaverum Brazil, said: “The integration of the UNTR clinic into our portfolio marks an important step forward in advancing our long-term strategy in Greater São Paulo. This is a region where population growth and healthcare demand continue to rise – and where the need for reliable, high-quality renal care is critical. By strengthening our presence here, we are not only expanding access but also building meaningful partnerships with public and private stakeholders to serve patients across all care pathways”.
Paulo Cicogna, Medical Director for Diaverum Brazil, added: “Increasing capacity is only part of the equation – our true focus is on improving the quality and continuity of care for every patient. The UNTR clinic brings strong clinical foundations and a shared culture of patient-centred care, which we will enhance further through Diaverum’s standardised medical protocols, training programmes, and digital tools. This is another important step toward a more integrated and efficient renal care system in Brazil”.
-ENDS-
Media contacts:
Marianna Sofocleous
Global Communications & Editorial Director
marianna.sofocleous@diaverum.com
About Diaverum:
Diaverum is a Swedish-born, multinational healthcare organisation that provides life-enhancing renal care to patients with chronic kidney disease, empowering them to live fulfilling lives.
Our vision is to transform renal care, delivering and broadening access to the highest quality of kidney care for patients around the world. At the heart of what we do is our standardised care delivery model, continuously evolving digital & AI infrastructure and people caring for patients with competence, passion and inspiration.
As a global leader and the largest independent renal service provider in Europe, we have 13,500 healthcare professionals caring for around 42,000 patients across 450 clinics in 24 countries globally. We provide renal care personalised to patients’ needs and choices, offering a portfolio of treatments ranging from preventive care, haemodialysis, peritoneal dialysis and home care, to the coordination of patients’ comorbidities and holiday dialysis.
Founded in 1991 in Malmö, Sweden, Diaverum is part of the M42 group of companies, the global health champion powered by artificial intelligence (AI), technology and genomics to advance innovation in health for people and the planet.
